AT1 4.76% 2.2¢ atomo diagnostics limited

Media Update, page-1280

  1. 1,096 Posts.
    lightbulb Created with Sketch. 66
    Some comments on here assume that the antibody test is an either or comparison with antigen.
    Found this interview with Atomo interesting ( Oct 29 )

    "Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather in its cap after authorities approved its nasal swab antigen test for COVID-19 to be used by medical professionals.

    Unlike most nasal swabs on the market that need to be sent to the lab for processing, the Atomo COVID-19 antigen test can be processed at the point of care with results available after 10 minutes."

    https://hotcopper.com.au/data/attachments/3753/3753746-27ea061e77c0cf9f47b086f1f05c7af3.jpg
    So Atomo sells antigen and antibody together in cost-effective deals designed to deliver the best possible testing results.
    Over time, they can package in other types of tests. General immunity tests that screen workers for some of the 40 possible applications for the technology.

 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $14.06M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $3.386K 161.5K

Buyers (Bids)

No. Vol. Price($)
2 318701 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 125713 2
View Market Depth
Last trade - 15.58pm 23/08/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.